Surveillance for Early Liver Injuries Caused by Xianlin Gubao Pill.

Clinical trial NCT03091556 · UNKNOWN

Trial details

NCT number: NCT03091556
Sponsor: Beijing 302 Hospital
Status: UNKNOWN
Study type: OBSERVATIONAL

Drug-Induced Liver Injury

Start date: 2017-03-25
Primary completion: 2017-12-31
Enrollment: 1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.